Australia's Archer Materials gains on partnership for kidney testing device
31/03/2025 02:08
** Shares of Archer Materials AXE.AX rise as much as 13.3% to A$0.34, highest level since February 26 ** Semiconductor technology company enters partnership with Hylid Diagnostics to develop an at-home testing device for chronic kidney disease as part of its Biochip project ** About 279,150 shares change hands by 0057 GMT, 1.3 times the 30-day average volume of shares ** Stock down 48.3% this year, as of last close (Reporting by Sherin Sunny in Bengaluru) ((Sherin.Sunny@thomsonreuters.com;))